Most pharma teams are still trying to force AI into 20‑year‑old GxP processes — but the playbook they need already exists, and it didn’t come from EMA or FDA.
A pharma VP told me the moment everything changed: ‘We thought we knew our customers—until our data finally started talking to each other.’ What happened next shocked the entire team…
70% of pharma AI pilots skip formal governance—and leaders are shocked when audits hit
The biggest shock in clinical research this year? Smaller trials are winning—and the data is proving it.
The most expensive GMP error I ever saw? It wasn’t caused by equipment… it was caused by a training task someone thought had been completed.
In just 5 years, your hospital won’t look anything like it does today — and most leaders still don’t see what’s coming.
